Literature DB >> 14559288

Alkaloids and a pimarane diterpenoid from Strychnos vanprukii.

Piyanuch Thongphasuk1, Rutt Suttisri, Rapepol Bavovada, Robert Verpoorte.   

Abstract

From the stem of Strychnos vanprukii, a gluco-indole alkaloid, 3,4-dehydropalicoside, and a pimarane diterpenoid, 7 beta-hydroxypimara-8,15-dien-14-one, were isolated together with four known alkaloids: palicoside, 3,4,5,6-tetradehydropalicoside, akagerine and 17-O-methylakagerine. The structures of these compounds were elucidated based on spectroscopic evidence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559288     DOI: 10.1016/s0031-9422(03)00508-9

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  3 in total

1.  Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.

Authors:  Paula S Lage; Miguel A Chávez-Fumagalli; Juliana T Mesquita; Laís M Mata; Simone O A Fernandes; Valbert N Cardoso; Manuel Soto; Carlos A P Tavares; João P V Leite; Andre G Tempone; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

2.  Some Strychnos spinosa (Loganiaceae) leaf extracts and fractions have good antimicrobial activities and low cytotoxicities.

Authors:  Adamu Imam Isa; Maurice Ducret Awouafack; Jean Paul Dzoyem; Mohammed Aliyu; Rabiu AbduSsalam Magaji; Joseph Olusegun Ayo; Jacobus Nicolaas Eloff
Journal:  BMC Complement Altern Med       Date:  2014-11-27       Impact factor: 3.659

3.  Strychnos pseudoquina and Its Purified Compounds Present an Effective In Vitro Antileishmanial Activity.

Authors:  Paula Sousa Lage; Pedro Henrique Rocha de Andrade; Amanda de Santana Lopes; Miguel Angel Chávez Fumagalli; Diogo Garcia Valadares; Mariana Costa Duarte; Daniela Pagliara Lage; Lourena Emanuele Costa; Vivian Tamietti Martins; Tatiana Gomes Ribeiro; José Dias de Souza Filho; Carlos Alberto Pereira Tavares; Rodrigo Maia de Pádua; João Paulo Viana Leite; Eduardo Antonio Ferraz Coelho
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-30       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.